Thank you for that.
I'm curious. I guess this is probably a bigger question that is not just related to this amendment.
You mentioned the administrative checkpoint. Could you comment on reporting requirements specifically related to this amendment in the bigger picture as well when it comes to the impact this amendment would have specifically on research institutions, on public and private entities that are doing testing currently, whether those are companies or departments of universities?
I'm wondering about the administrative and reporting requirements associated with what's being proposed here.